| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Ethics > Some Thoughts - Leadership and Values |
|
Main Subject - Some Thoughts - Leadership and Values
I took a course in social deviance several years ago. What this course helped me understand is that societies and cultures have their own definitions of values and they According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product exist on a continuum. Anything outside the boarders of the continuum is deviant. In relation to values, both ultraliberal and ultraconservative are inappropriate values ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ithin the society or culture’s definition. The problem with this is how one society and another define the same value. When one experiences a significant emotional even lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t it may tear the fabric of their values leaving them with the options you identify of confirmation, rejection, or modification. Further, when one wants to assimilate in here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe o a new culture, one tends to accept the values of that culture in spite of ones acculturated values. We have evidence of this from our study of Paul’s letters last ter d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro m. Paul had the option to reject his calling. He did modify his values accepting the values of the new sect growing out of Jerusalem. We read an interesting argument in ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Joas (2000) on self and values. We base our value system on how we define ourselves, a declaration of what we commit to and from what we distance ourselves. Therefore, o easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ur self-defining becomes a “strongly valued good” (pg. 130). We make qualitative distinctions on our actions creating a value preference self-defining what is important. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Joas' suggestion takes into account life-long development of values through interaction with others. Johnson (2005) writes of casting light that spiritual development g and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ oes through several stages. At the primal level, spiritual development is of trust of parents and caregivers. Progressing, one begins to internalize beliefs and values o ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi family and those barrowed from others, until one has an “individuative-reflective faith” (pg 111) of doubt and question. At mid-life, one accepts others’ beliefs and va ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ues and may reach the stage “universalizing faith” (pg. 112) desiring to serve a greater good beyond oneself. In a biblical world view, both seem supporting Paul in 1 C dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod orinthians 13:11, “When I was a child, I used to speak like a child, think like a child, reason like a child; when I became a man, I did away with childish things.” Joa cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin (2000) opens us to a new level of value development through the internalizing of new experiences and “interpretation of complex activity in which we strive for harmony… tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ” (pg. 135). Values change based on experience coupled with new experiences and new “ways of life and practices” (pg. 135). Leaders within organizations who are founded t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel spiritually display inward, outward, and corporate disciplines that aid in developing new values in workers. Inward values include disciplines of meditation, prayer, fas ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ting, and study. Outward disciplines involve simplicity, solitude, submission, and service. Corporate disciplines shown by leaders are confession, worship, guidance, and y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products celebration. Johnson (2005) presents these 12 disciplines of individual and corporate values as a way to seek a level of leader servanthood. Compare Joas and Johnson wi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de th the spiritual gifts found in 1 Corinthians 12:7-11, the similarity is striking. References: Holy Bible: New International Version Joas, H. (2000). The Genesis of V elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip lues. Chicago: University of Chicago Press.
Johnson, C. E. (2005). Meeting the Ethical Challenges of Leadership: Casting Light or Shadow. Thousand Oaks: Sage Publishers tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Do You Need a War Room? Life in the Command Center TPM and Lean Production, is It Worth the Effort?
|